Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity

Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)

Published:2018-12-06 Issue:1 Volume:13 Page:66-74
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Gentile Ivan,Scotto Riccardo^ORCID,Coppola Carmine,Staiano Laura,Amoruso Daniela Caterina,De Simone Teresa,Portunato Federica,De Pascalis Stefania,Martini Salvatore,Macera Margherita,Viceconte Giulio,Tosone Grazia,Buonomo Antonio Riccardo,Borgia Guglielmo,Coppola Nicola

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/article/10.1007/s12072-018-9914-6/fulltext.html

Reference31 articles.

1. Borgia G, Maraolo AE, Buonomo AR, Scotto R, Gentile I. The therapeutic potential of new investigational hepatitis C virus translation inhibitors. Expert Opin Investig Drugs 2016;25(10):1209–1214

2. Gentile I, Maraolo AE, Buonomo AR, Zappulo E, Borgia G. The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C. Expert Opin Drug Discov 2015;10(12):1363–1377

3. Gentile I, Scotto R, Zappulo E, Buonomo AR, Pinchera B, Borgia G. Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development. Expert Opin Investig Drugs 2016;25(5):557–572

4. Curry MP, Tapper EB, Bacon B, et al. Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naive, genotype 1 hepatitis C infected patients. Aliment Pharmacol Ther 2017;46(5):540–548

5. Nelson DR, Cooper JN, Lalezari JP, et al. All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. Hepatology (Baltimore, MD) 2015;61(4):1127–1135

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recompensation of Chronic Hepatitis C–Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program;Gastroenterology;2024-08

2. Advancing hepatic recompensation: Baveno VII criteria and therapeutic innovations in liver cirrhosis management;World Journal of Gastroenterology;2024-06-21

3. Chinese consensus on the management of liver cirrhosis;Journal of Digestive Diseases;2024-06

4. Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery;Trends in Endocrinology & Metabolism;2024-06

5. Liver cirrhosis reversal and recompensation: Existing evidence and future prospects;World Chinese Journal of Digestology;2024-05-28